Literature DB >> 21617521

Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Joel Mack1, Peter Rabins, Karen Anderson, Susanne Goldstein, Stephen Grill, Elaina S Hirsch, Susan Lehmann, John T Little, Russell L Margolis, Justin Palanci, Gregory Pontone, Howard Weiss, James R Williams, Laura Marsh.   

Abstract

OBJECTIVES: : To determine the prevalence of psychotic phenomena, including minor symptoms, in a Parkinson disease (PD) sample and compare the clinical correlates associated with the various psychotic phenomena. To evaluate the extent to which cases met National Institute of Neurological Diseases and Stroke (NINDS)/National Institute of Mental Health (NIMH)-proposed criteria for PD-associated psychosis.
METHODS: : A total of 250 patients with idiopathic PD and Mini Mental State Exam scores greater than 23 from three community-based movement disorder clinics underwent comprehensive research diagnostic evaluations by a geriatric psychiatrist as part of a study on mood disorders in PD. Psychotic symptoms were categorized using a checklist, which included a breakdown of hallucinations, delusions, and minor symptoms. Clinical characteristics of groups with minor and other psychotic symptoms were compared. The NINDS/NIMH criteria for PD-psychosis were retrospectively applied.
RESULTS: : Of the total sample, 26% of patients were found to have any current psychotic symptoms, with 47.7% of those having isolated minor symptoms, and 52.3% having hallucinations and/or delusions. Compared to those with no current psychiatric symptoms, minor symptoms were associated with more depressive symptoms and worse quality of life, and 90.8% of those with psychotic symptoms fulfilled the NINDS/NIMH proposed criteria.
CONCLUSIONS: : Psychotic symptoms are common in PD patients, with minor psychotic phenomena present in nearly half of affected patients in a community-based sample. Psychotic symptoms, including minor phenomena, were clinically significant. The NINDS/NIMH PD-psychosis criteria captured the clinical characteristics of psychosis as it relates to PD. Longitudinal studies are needed to determine whether minor psychotic symptoms represent a precursor to hallucinations and delusions, and to further validate diagnostic criteria.

Entities:  

Mesh:

Year:  2012        PMID: 21617521      PMCID: PMC3168582          DOI: 10.1097/JGP.0b013e31821f1b41

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  36 in total

1.  Prospective longitudinal assessment of hallucinations in Parkinson's disease.

Authors:  C G Goetz; S Leurgans; E J Pappert; R Raman; A B Stemer
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

4.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

5.  Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.

Authors:  N Giladi; T A Treves; D Paleacu; H Shabtai; Y Orlov; B Kandinov; E S Simon; A D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

6.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

Authors:  D Aarsland; J P Larsen; J L Cummins; K Laake
Journal:  Arch Neurol       Date:  1999-05

7.  Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

Authors:  D Aarsland; J P Larsen; E Tandberg; K Laake
Journal:  J Am Geriatr Soc       Date:  2000-08       Impact factor: 5.562

8.  Prospective study of hallucinations and delusions in Parkinson's disease.

Authors:  S Holroyd; L Currie; G F Wooten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

9.  How common are complications of Parkinson's disease?

Authors:  Anette Schrag; Yoav Ben-Shlomo; Niall Quinn
Journal:  J Neurol       Date:  2002-04       Impact factor: 4.849

10.  Psychiatric comorbidities in patients with Parkinson disease and psychosis.

Authors:  L Marsh; J R Williams; M Rocco; S Grill; C Munro; T M Dawson
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

View more
  32 in total

1.  Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.

Authors:  Maiya R Geddes; Yanmei Tie; John D E Gabrieli; Scott M McGinnis; Alexandra J Golby; Susan Whitfield-Gabrieli
Journal:  Cortex       Date:  2015-11-05       Impact factor: 4.027

2.  Progress Regarding Parkinson's Disease Psychosis: It's No Illusion.

Authors:  Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2016-08-11

Review 3.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

4.  Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

Authors:  Jacob Taylor; William S Anderson; Jason Brandt; Zoltan Mari; Gregory M Pontone
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-03       Impact factor: 4.105

5.  New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.

Authors:  Michael A Kelberman; Elena M Vazey
Journal:  Curr Pharmacol Rep       Date:  2016-09-28

Review 6.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

7.  A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach.

Authors:  Pablo Martinez-Martin; Belen Frades-Payo; Luis Agüera-Ortiz; Angel Ayuga-Martinez
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

Review 8.  Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis.

Authors:  Harini Sarva; Claire Henchcliffe
Journal:  Ther Adv Neurol Disord       Date:  2016-10-03       Impact factor: 6.570

9.  Delusions in Parkinson's Disease: A Systematic Review of Published Cases.

Authors:  Nicola Warren; Cullen O'Gorman; Zena Hume; Steve Kisely; Dan Siskind
Journal:  Neuropsychol Rev       Date:  2018-08-02       Impact factor: 7.444

Review 10.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.